QuantiFERON Change During Anti-tuberculosis Medication
Information source: Armed Forces Capital Hospital, Republic of Korea
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Tuberculosis; Interferon-gamma Release Assay
Phase: N/A
Status: Completed
Sponsored by: Armed Forces Capital Hospital, Republic of Korea
Summary
The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT)
during the treatment of active tuberculosis.
Clinical Details
Official title: The Change in Level of Interferon-gamma Assay in Active Tuberculosis Patients During Treatment
Study design: Observational Model: Cohort, Time Perspective: Prospective
Detailed description:
Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each
subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level
of interferon-gamma, and reversion and conversion of this test.
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- All subjects with active tuberculosis
Exclusion Criteria:
- Subjects who cannot complete study
- Subjects who have taken anti-tuberculosis medication for more than a month before
visit of our hospital
Locations and Contacts
Armed Forces Capital Hospital, Seongnam, Gyeonggi-do 463-040, Korea, Republic of
Additional Information
Starting date: May 2008
Last updated: June 11, 2010
|